The skinny on GLP-1 medications
The GLP-1 market seems to be exploding. What’s new?
There’s so much information about GLP-1, and it’s changing overnight. Now, there’s a new drug—Foundayo—made by Lilly. What’s notable is that Lilly didn’t seek approval for type 2 diabetes, only weight loss.
You can buy GLP-1 drugs directly from the manufacturer and other companies online. But the problem is polypharmacy. People may not want to mention that they’re taking a GLP-1 on their medical history.
Join us in Medical History Mysteries as we talk about the latest on GLP-1 medications, side effects, and more.
Thumbnail image credit: Love Employee / iStock / Getty Images Plus
More Medical History Mysteries videos …
- Anticoagulant reversal agent that has been cancelled
- Hair growth meds for women and preventing hair loss
The Dental Economics Network brings you the best content from Dental Economics, RDH, DentistryIQ, and Perio-Implant Advisory.
Editor’s note: This article first appeared in Clinical Insights newsletter, a publication of the Endeavor Business Media Dental Group. Read more articles and subscribe.
About the Author
Pamela Maragliano, DMD
Pamela Maragliano, DMD, is the chief editor of Dental Economics. Based in Salem, Massachusetts, Dr. Maragliano began her clinical career as a dental hygienist. She went on to attend Tufts University School of Dental Medicine, where she earned her doctorate in dental medicine. She then attended the University of California, Los Angeles, School of Dental Medicine, where she became board-certified in prosthodontics. Dr. Maragliano owns a private practice, Salem Dental Arts, and lectures on a variety of clinical topics. You may contact her at [email protected].
Tom Viola, RPh, CCP
With more than 30 years’ experience as a board-certified pharmacist, clinical educator, professional speaker, and published author, Tom Viola, RPh, CCP, has earned the reputation as the go-to specialist for making pharmacology practical and useful for dental teams. He is the founder of Pharmacology Declassified and is a member of the faculty of more than 10 dental professional degree programs. Viola has contributed to several professional journals and pharmacology textbooks, and currently serves as a consultant to the American Dental Association’s Council on Scientific Affairs.